About Cytel Inc.
Cytel Inc. is the leading provider of clinical trial design services and specialized statistical applications primarily for the biopharmaceutical, medical device, academic and government research markets. 47 out of the top 50 biopharmaceutical companies use Cytel software to design, simulate and analyze their clinical trials.
Cytel provides study sponsors with innovative tools, training and consultation to increase process efficiencies and reduce development costs.
Products & Services
For over 20 years, Cytel has been the premier software and services provider for the design, analysis and better implementation of clinical trials. Cytel applications, training and consultative services help clinical trial sponsors increase research efficiencies and reduce development costs in early and later stage studies.
Cytel’s application, East® is used by biostatisticians and clinicians at hundreds of commercial sites, throughout academia and by regulators to design, simulate and monitor group sequential and adaptive clinical trials. First introduced in 2009, Cytel's SiZ® is the first software to combine design, simulation and trial analysis in one application. Over 10,000 customers also use Cytel's analysis software StatXact® and LogXact® for exact statistical inference and logistics regression.
The company’s Clinical Research Services division, established in 2005, is a key contributor to Cytel's continuing growth. This unit's major service lines include: clinical program design, trial implementation support, clinical data submission, and collaborative development. Key services group growth drivers include the company's unmatched experience with adaptive clinical trial planning and implementation.
Cytel’s products and services are sold worldwide through a direct sales and business development team coupled with an inside sales force, global distributor network, Internet sales and OEM arrangements. The company forecasts continued strong demand for both products and services.
With groundbreaking solutions, highly-respected founders and advisory board members, a top-notch management team and a customer base that includes most of the world’s leading biopharmaceutical companies, Cytel is well positioned for long-term growth and market leadership.